Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy

Table 4 Comparison of characteristics adjusted among patients receiving single-low-dose aspirin in the continuous low-dose aspirin group and the discontinuous low-dose aspirin group

	Continuous LDA (n = 56)	Discontinuous LDA (n = 39)	P value
Age, mean (SD), yr	76.5 (7.628)	74.8 (5.961)	0.255
Sex, male, n (%)	37 (66.1)	32 (82.1)	0.105
BMI, mean (SD), yr	22.2 (3.029)	23.6 (2.958)	0.025
Comorbidity, n (%)
Hypertension	41 (73.2)	24 (61.5)	0.266
Diabetes mellitus	13 (23.2)	13 (33.3)	0.351
Renal failure	3 (5.4)	1 (2.6)	0.642
Coronary artery diseases	41 (73.2)	25 (64.1)	0.372
Longitudinal location, n (%)
Upper	8 (14.3)	4 (10.3)	0.643
Middle	28 (50.0)	17 (43.6)
Lower	20 (35.7)	18 (46.2)
Macroscopic findings, n (%)
Depressed	20 (35.7)	16 (41.0)	0.669
Non-depressed	36 (64.3)	23 (59.0)

BMI: Body mass index; LDA: Low-dose aspirin; SD: Standard deviation.